Cargando…

HIV/HCV Co-infection, Liver Disease Progression, and Age-Related IGF-1 Decline

BACKGROUND: We have previously reported that persons co-infected with HIV and hepatitis C virus (HCV) had liver disease stages similar to HIV-uninfected individuals who were approximately 10 years older. Insulin-like growth factor 1(IGF-1) levels have long been known to decline with advancing age in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quinn, Jeffrey, Astemborski, Jacquie, Mehta, Shruti H., Kirk, Gregory D., Thomas, David L., Balagopal, Ashwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pathogens and Immunity 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425162/ https://www.ncbi.nlm.nih.gov/pubmed/28503671 http://dx.doi.org/10.20411/pai.v2i1.183

Ejemplares similares

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons
por: Balagopal, Ashwin, et al.
Publicado: (2015)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland
por: Buresh, Megan, et al.
Publicado: (2020)

Progression of Biopsy-Measured Liver Fibrosis in Untreated Patients with Hepatitis C Infection: Non-Markov Multistate Model Analysis
por: Bacchetti, Peter, et al.
Publicado: (2011)

Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland
por: Cepeda, Javier A., et al.
Publicado: (2019)

The health and social consequences during the initial period of the COVID-19 pandemic among current and former people who inject drugs: A rapid phone survey in Baltimore, Maryland
por: Genberg, Becky L., et al.
Publicado: (2021)

Reducing injection intensity is associated with decreased risk for invasive bacterial infection among high-frequency injection drug users
por: Islam, Salequl, et al.
Publicado: (2019)

Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in Baltimore, Maryland
por: Patel, Eshan U., et al.
Publicado: (2023)

Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland
por: Baker, Pieter, et al.
Publicado: (2023)

A Cross Sectional Analysis of the Role of the Antimicrobial Peptide Cathelicidin in Lung Function Impairment within the ALIVE Cohort
por: Lambert, Allison A., et al.
Publicado: (2014)

The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies
por: Martin, Alyssa R., et al.
Publicado: (2020)

Mitochondrial DNA copy number is associated with incident chronic kidney disease and proteinuria in the AIDS linked to the intravenous experience cohort
por: Tewari, Sakshi R., et al.
Publicado: (2023)

Racial differences in α4β7 expression on CD4(+) T cells of HIV-negative men and women who inject drugs
por: Martin, Alyssa R., et al.
Publicado: (2020)

Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users
por: Drummond, M Bradley, et al.
Publicado: (2011)

Temporal association of pre-pandemic perceived social support with psychological resilience and mental well-being during the COVID-19 pandemic among people with a history of injection drug use
por: Patel, Eshan U., et al.
Publicado: (2023)

Brief Report: HIV Is Associated With Impaired Pulmonary Diffusing Capacity Independent of Emphysema
por: Raju, Sarath, et al.
Publicado: (2022)

Mortality by cause of death during year 1 of the COVID-19 pandemic in a cohort of older adults from Baltimore Maryland who have injected drugs()
por: Feder, Kenneth A., et al.
Publicado: (2022)

Fibrosis progression in paired liver biopsies from HIV/HCV co-infected patients
por: Schiavini, Monica, et al.
Publicado: (2011)

24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
por: Pérez-Is, Laura, et al.
Publicado: (2022)

Progress in eradication of HCV in HIV positive patients with significant liver fibrosis in Vienna
por: Steiner, Sebastian, et al.
Publicado: (2017)

HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection
por: Vali, Bahareh, et al.
Publicado: (2008)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users
por: Drummond, Michael B, et al.
Publicado: (2014)

Are T cells the only HIV-1 reservoir?
por: Kandathil, Abraham Joseph, et al.
Publicado: (2016)

Liver disease progression in HIV/HCV co-infected patients: a role for metalloproteinases and their specific inhibitors
por: Sasongko, Priyo
Publicado: (2006)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

Erratum to: Are T cells the only HIV-1 reservoir?
por: Kandathil, Abraham Joseph, et al.
Publicado: (2017)

HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients
por: Abravanel, Florence, et al.
Publicado: (2012)

Inferring Viral Dynamics in Chronically HCV Infected Patients from the Spatial Distribution of Infected Hepatocytes
por: Graw, Frederik, et al.
Publicado: (2014)

COVID-19 Vaccine Hesitancy and Vaccination Status in a Community-Based Cohort of People Who Inject Drugs in Baltimore, Maryland, March–June 2021
por: Cepeda, Javier A., et al.
Publicado: (2022)

Plasma cathelicidin and longitudinal lung function in current and former smokers
por: Burkes, Robert M., et al.
Publicado: (2019)

Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
por: Schmid, Patrick, et al.
Publicado: (2015)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

The effects of Maraviroc on liver fibrosis in HIV/HCV co-infected patients
por: Ortega Gonzalez, Enrique, et al.
Publicado: (2014)

Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis
por: Merchante, Nicolás, et al.
Publicado: (2015)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs
por: Sosnowski, David W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pobjijh375bf738lqokckhthgr